Skip to main content

Table 1 Baseline patient demographics

From: Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Number of patients

25

Age, y

 Median

67

 Min-max

43–89

Sex, n (%)

 Male

17 (68.0)

 Female

8 (32.0)

Extent of disease, n (%)

 MIBC

4 (16.0)

 mBCa

21 (84.0)

Prior chemotherapy, n (%)

15 (60.0)

Follow-up status, n (%)

 Deceased

11 (44.0)

 Alive

8 (32.0)

 No follow-up

6 (24.0)

Median days to blood draw

1075

Survival after CTC draw, days

 Median

167

 Min-max

40–599

  1. Abbreviations: Y, years, Min, minimum, Max, maximum, n, number of patients per category